Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution.".
Press Release Feb 07 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Aurobindo Pharma
- Press Release (Revised) Jan 04 2023
- Press Release Dec 27 2022
- Press Release Nov 23 2022
- Press Release Nov 18 2022
- Press Release Nov 12 2022
Later from Aurobindo Pharma
- Aurobindo Pharma Ltd Press Release Mar 08 2023
- Press Release Mar 30 2023
- Press Release May 26 2023
- Press Release May 27 2023
- Press Release Jun 23 2023
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma